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Abstract	  
In	  silico	  experimental	  modeling	  of	  cancer	  involves	  combining	  findings	  from	  biological	  literature	  with	  computer-­‐based	  models	  of	  biological	  systems	  in	  order	  to	  conduct	  investigations	  of	  hypotheses	  entirely	  in	  the	  computer	  laboratory.	  In	  this	  paper,	  we	  discuss	  the	  use	  of	  in	  silico	  modeling	  as	  a	  precursor	  to	  traditional	  clinical	  and	  laboratory	  research,	  allowing	  researchers	  to	  refine	  their	  experimental	  programs	  with	  an	  aim	  to	  reducing	  costs	  and	  increasing	  research	  efficiency.	  We	  explain	  the	  methodology	  of	  in	  silico	  experimental	  trials	  before	  providing	  an	  example	  of	  in	  silico	  modeling	  from	  the	  biomathematical	  literature	  with	  a	  view	  to	  promoting	  more	  widespread	  use	  and	  understanding	  of	  this	  research	  strategy.	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1.	  Introduction	  Traditional	  laboratory-­‐based	  cancer	  research	  involves	  expensive	  trial	  and	  error	  experimental	  strategies	  applied	  to	  humans,	  animals	  and	  their	  harvested	  tissues.	  “In	  silico	  experimentation”,	  the	  coupling	  of	  current	  computing	  technologies	  with	  mathematical	  or	  theoretical	  characterizations	  of	  cancer	  cell	  biology,	  provides	  a	  novel	  approach	  to	  guiding	  the	  early	  stages	  of	  hypothesis	  development	  and	  experimental	  design	  that	  has	  the	  potential	  to	  create	  subsequent	  efficiencies	  and	  cost	  savings	  in	  the	  laboratory.	  This	  computational	  approach	  is	  advantageous	  because	  it	  allows	  vast	  numbers	  of	  experiments	  to	  be	  carried	  out	  that	  are	  easily	  observed	  at	  any	  desired	  level	  of	  detail	  and	  can	  be	  repeated	  and	  controlled	  at	  will.	  It	  seems	  difficult	  to	  argue	  that	  pre-­‐clinical	  studies	  in	  cancer	  biology	  are	  expensive.	  Such	  studies	  involving	  in	  vitro	  and	  in	  vivo	  animal	  experiments	  involve	  hypothesis	  generation	  and	  testing	  to	  determine	  whether	  further	  trials	  are	  warranted,	  and	  are	  extremely	  costly	  both	  in	  terms	  of	  researchers’	  time	  and	  the	  associated	  financial	  investment.	  Costs	  such	  as	  laboratory	  setup,	  equipment	  and	  space,	  time	  spent	  by	  academics	  training	  others,	  and	  the	  time,	  equipment	  and	  
materials	  costs	  involved	  in	  repetitive,	  hands-­‐on	  experimental	  work,	  all	  contribute	  to	  the	  expense	  of	  laboratory-­‐based	  experimental	  research.	  Our	  contention	  in	  this	  paper,	  a	  view	  shared	  by	  many	  researchers	  in	  the	  closely	  related	  fields	  of	  computational,	  theoretical	  and	  mathematical	  biology,	  is	  that	  in	  
silico	  experiments	  can	  be	  used	  as	  precursors	  to,	  or	  in	  combination	  with,	  pre-­‐clinical	  experimental	  studies	  to	  provide	  guidance	  for	  the	  development	  of	  more	  refined	  hypotheses	  and	  experimental	  studies.	  In	  silico	  and	  mathematical	  modeling	  lends	  itself	  to	  the	  determination	  of	  preliminary	  information	  such	  as	  toxicity,	  pharmacokinetics	  and	  efficacy,	  which	  can	  then	  be	  used	  to	  guide	  pre-­‐clinical	  and	  clinical	  studies.	  
In	  silico	  experimentation	  involves	  the	  combination	  of	  biological	  data	  and	  expert	  opinion	  with	  mathematical	  and	  computer-­‐based	  representations	  to	  construct	  models	  of	  biology.	  Computer-­‐based	  experiments	  can	  then	  be	  carried	  out	  using	  these	  models	  rather	  than,	  or	  in	  combination	  with,	  laboratory	  research.	  Using	  parameter	  distributions	  based	  on	  current	  expert	  opinion	  (“fuzzy”	  inputs)	  or	  actual	  biological	  data	  (random	  variables)	  as	  inputs	  into	  the	  in	  silico	  models,	  it	  is	  possible	  to	  create	  what	  are	  effectively	  “computational	  patients”	  upon	  which	  to	  experiment.	  It	  is	  of	  course	  also	  possible	  to	  consider	  smaller	  scale	  experiments	  and	  even	  multi-­‐scale	  experiments,	  conducted	  on	  molecular,	  cellular	  and	  tissue/organ	  levels.	  Appropriate	  use	  of	  in	  silico	  models	  involves	  making	  predictions	  based	  on	  experimental	  data	  and	  expert	  information	  and	  allows	  the	  models	  to	  be	  effectively	  used	  to	  inform	  clinical	  trials	  with	  a	  view	  to	  reducing	  costs	  and	  increasing	  efficiency.	  To	  provide	  an	  example,	  consider	  the	  study	  of	  cell	  transfer	  therapy	  for	  metastatic	  melanoma	  patients	  of	  Rosenberg	  et	  al.	  [1].	  The	  authors	  commented	  on	  the	  difficulty	  of	  deriving	  meaningful	  results	  from	  human	  experiments	  because	  of	  the	  variations	  in	  cell	  types,	  tumor	  types,	  immune	  states,	  and	  more	  fundamentally	  the	  human	  subjects	  themselves.	  While	  Rosenberg	  et	  al.	  suggest	  a	  solution	  to	  such	  a	  problem	  is	  to	  treat	  the	  same	  patient	  in	  differing	  ways	  over	  a	  period	  of	  time,	  another	  more	  ethical	  and	  flexible,	  and	  less	  hazardous	  method	  is	  through	  the	  use	  of	  in	  silico	  models	  and	  experimentation.	  This	  approach	  was	  used	  in	  the	  model	  discussed	  in	  Section	  3.	  	  There	  is	  a	  rich	  history	  of	  theoretical	  studies	  involving	  mathematical	  and	  computational	  approaches	  to	  studying	  cancer.	  Burton	  and	  Greenspan	  pioneered	  the	  mathematical	  modeling	  of	  tumor	  growth	  with	  models	  of	  growth	  dynamics	  explained	  as	  a	  problem	  of	  diffusion	  [2-­‐5].	  Since	  that	  time,	  theoretical	  studies	  of	  most	  aspects	  of	  tumor	  growth	  and	  related	  processes	  have	  been	  investigated	  at	  least	  to	  some	  extent,	  using	  various	  different	  methodologies	  including	  differential	  equations,	  stochastic	  models	  and	  cellular	  automata.	  Araujo	  and	  McElwain	  provide	  an	  excellent	  review	  of	  the	  mathematical	  modeling	  work	  carried	  out	  up	  to	  middle	  of	  the	  last	  decade	  [6].	  More	  recently,	  Alarcon	  et	  al.	  [7],	  Mallet	  and	  coworkers	  [8-­‐9]	  and	  Ferreira	  et	  al.	  [10-­‐11]	  have	  used	  a	  new	  paradigm	  –	  that	  of	  spatiotemporal,	  stochastic	  models	  using	  hybrid	  cellular	  automata	  techniques	  –	  to	  represent	  “computational	  patients”	  or	  “in	  silico	  experiments”	  in	  a	  new	  direction	  for	  cancer	  research.	  This	  experimental	  paradigm	  extends	  the	  traditional	  mathematical	  modeling	  of	  cancer	  to	  incorporate	  computational	  simulations	  that	  
are	  parameterized	  in	  such	  a	  way	  to	  represent	  different	  patients	  or	  different	  experiments.	  It	  is	  also	  becoming	  more	  common	  to	  find	  mathematical	  studies	  appearing	  in	  the	  cancer	  literature.	  Utley	  et	  al.	  for	  example,	  discuss	  improvement	  in	  survival	  rates	  resulting	  from	  post-­‐operative	  chemotherapy	  for	  lung	  cancer	  patients	  [12].	  They	  note	  that	  the	  marginal	  (5%)	  survival	  rate	  improvement	  due	  to	  chemotherapy	  may	  be	  outweighed	  for	  some	  patients	  by	  the	  morbidity	  due	  to	  the	  treatment,	  and	  that	  further	  trials	  do	  not	  actually	  improve	  information	  provided	  to	  patients,	  but	  rather	  improve	  the	  certainty	  of	  that	  prediction.	  Utley	  et	  al.	  propose	  the	  use	  of	  a	  mathematical	  model,	  utilizing	  patient-­‐specific	  pathological	  cancer	  stage	  data	  combined	  with	  existing	  techniques,	  to	  arrive	  at	  better	  evidence	  for	  informing	  patients	  regarding	  their	  post-­‐operative	  treatment	  choices.	  	  In	  a	  study	  more	  at	  the	  pre-­‐clinical	  stage	  of	  research,	  de	  Pillis	  et	  al.	  describe	  a	  differential	  equation	  based	  model	  for	  the	  interactions	  between	  a	  growing	  tumor,	  natural	  killer	  cells	  and	  CD8+	  T	  cells	  of	  the	  host	  immune	  system	  [13].	  With	  a	  view	  to	  understanding	  how	  the	  immune	  system	  assists	  in	  rejecting	  growing	  tumors,	  de	  Pillis	  et	  al.	  present	  mathematical	  descriptions	  of	  key	  mechanisms	  in	  the	  immune	  response	  before	  fitting	  the	  model	  to	  data	  from	  published	  mouse	  and	  human	  studies.	  A	  parameter	  sensitivity	  analysis	  reveals	  the	  key	  role	  of	  a	  patient-­‐specific	  variable	  and	  that	  the	  model	  may	  in	  fact	  provide	  a	  means	  to	  predict	  positive	  response	  of	  particular	  patients	  to	  treatment.	  Mallet	  and	  de	  Pillis	  [8]	  and	  later	  de	  Pillis	  et	  al	  [9]	  explored	  a	  particular	  type	  of	  in	  
silico	  model	  known	  as	  a	  hybrid	  cellular	  automata-­‐partial	  differential	  equation	  (CA-­‐PDE)	  model	  to	  describe	  the	  interactions	  between	  a	  growing	  tumor	  and	  the	  host	  immune	  response.	  A	  hybrid	  CA-­‐PDE	  model	  combines	  the	  traditional	  continuum	  methods	  of	  applied	  mathematics,	  such	  as	  macro-­‐scale	  reaction-­‐diffusion	  equations	  describing	  chemical	  concentrations,	  with	  more	  modern,	  individual	  or	  grid	  based	  automaton	  methods,	  which	  are	  used	  for	  describing	  individual	  cell	  level	  phenomena.	  The	  hybrid	  CA-­‐PDE	  modeling	  approach	  has	  been	  successfully	  used	  in	  the	  past	  to	  model	  tumor	  growth,	  chemotherapeutic	  treatment	  and	  the	  effects	  of	  vascularization	  on	  a	  growing	  tumor	  [7,10-­‐11,14].	  In	  Section	  3	  we	  discuss	  this	  model	  in	  some	  detail,	  explaining	  how	  the	  model	  is	  constructed	  as	  well	  as	  typical	  outputs	  of	  an	  in	  silico	  model	  of	  this	  type.	  
2.	  Methods	  –	  In	  Silico	  Trials	  While	  in	  vitro	  and	  in	  vivo	  models	  use	  actual	  biological	  materials	  and/or	  actual	  animals	  to	  investigate	  hypotheses	  and,	  for	  example,	  predict	  effectiveness	  of	  treatment	  strategies,	  in	  silico	  models	  use	  specifically	  designed	  computer	  programs	  to	  mimic	  these	  “real”	  experimental	  environments	  and	  to	  conduct	  computational	  experiments.	  There	  exists	  a	  number	  of	  different	  types	  of	  in	  silico	  model	  including	  differential	  equation	  models	  that	  track	  changes	  in	  quantities	  over	  time	  and/or	  space,	  network	  models	  that	  trace	  lines	  of	  probabilistic	  causation	  and/or	  correlation,	  discrete	  cellular	  automata	  or	  individual	  based	  models,	  and	  hybrids	  of	  all	  of	  these	  models.	  Rather	  than	  providing	  models	  of	  real	  biological	  phenomena	  and	  structures	  that	  have	  a	  basis	  in	  some	  sort	  of	  extracted	  tissue	  or	  a	  somehow-­‐related	  animal	  species,	  these	  in	  silico	  models	  are	  comprised	  of	  mathematical	  and	  computational	  representations	  such	  as	  formulae,	  equations	  
and/or	  computer	  programs.	  A	  key	  feature	  of	  such	  models	  is	  that	  they	  can	  be	  ‘parameterized’	  so	  that	  quantities	  or	  rates	  not	  known	  in	  the	  real	  world	  or	  which	  are	  specific	  to	  different	  experiments	  can	  be	  investigated	  via	  computational	  experiments,	  or	  as	  we	  dub	  them	  “in	  silico	  trials”.	  The	  concept	  of	  the	  in	  silico	  trial	  can	  be	  thought	  of	  as	  akin	  to	  clinical	  trials.	  	  Just	  as	  each	  patient	  in	  a	  clinical	  trial	  has	  their	  own	  set	  of	  characteristics	  such	  as	  height,	  age,	  status	  with	  regard	  to	  smoking	  and	  alcohol	  consumption	  and	  so	  on,	  so	  too	  we	  can	  run	  the	  program	  of	  an	  in	  silico	  model	  multiple	  times	  with	  varied	  parameters	  to	  produce	  “computational	  patients”	  in	  an	  in	  silico	  trial.	  	  The	  development	  of	  in	  silico	  model	  is	  often	  a	  process	  of	  cross-­‐disciplinary	  collaboration	  between	  cancer	  biologists	  and	  mathematicians	  or	  modelers.	  Generally,	  the	  initial	  stages	  involve	  the	  model-­‐builder	  obtaining	  an	  understanding	  of	  the	  tumor	  biology	  required	  for	  developing	  the	  in	  silico	  model.	  This	  will	  be	  a	  period	  of	  intense	  collaborative	  work	  involving	  discussions	  between	  all	  investigators	  and	  a	  review	  of	  the	  theoretical	  and	  experimental	  literature.	  The	  next	  stage	  involves	  abstraction	  of	  biological	  information	  into	  a	  mathematical	  or	  computational	  form	  –	  that	  is,	  building	  the	  update	  rules.	  This	  requires	  the	  creation	  of	  mathematical	  representations	  of	  relevant	  micro-­‐level	  biological	  phenomena	  and	  mechanisms	  (such	  as	  rates	  and	  results	  of	  cell	  division,	  methods	  for	  representing	  distributions	  of	  chemical	  molecules,	  interactions	  between	  antigen	  and	  antigen	  presenting	  cells,	  and	  so	  on)	  and	  the	  compilation	  of	  these	  into	  a	  macro-­‐level	  description	  of	  the	  real	  experimental	  situation.	  Following	  the	  development	  of	  the	  update	  rules,	  the	  algorithm	  for	  the	  entire	  process	  is	  computerized	  usually	  employing	  generic	  programming	  languages	  such	  as	  C++	  or	  with	  mathematical	  software	  such	  as	  MATLAB.	  This	  algorithm	  allows	  for	  the	  solution	  of	  the	  in	  silico	  model	  and	  facilitates	  easy	  simulation	  of	  large	  numbers	  of	  experiments	  –	  that	  is,	  repeated	  simulation	  of	  the	  model	  using	  many	  different	  parameter	  sets	  in	  order	  to	  mimic	  running	  slightly	  different	  experiments	  in	  the	  laboratory.	  This	  could	  reflect	  for	  example,	  an	  investigation	  of	  the	  effect	  of	  different	  quantities	  of	  gold	  nanoparticles	  on	  effectiveness	  of	  radiotherapy	  or	  the	  effect	  of	  different	  concentrations	  of	  chemotherapeutic	  treatments.	  While	  largely	  automated	  via	  the	  computer	  program,	  the	  simulation	  of	  the	  in	  silico	  model	  requires	  careful	  and	  continuous	  monitoring	  to	  ensure	  that	  computations	  converge	  (that	  is,	  solutions	  are	  obtained	  rather	  than	  computational	  errors)	  and	  to	  make	  adjustments	  to	  investigations	  when	  results	  of	  interest	  are	  observed.	  Following	  simulation	  of	  the	  in	  silico	  model,	  the	  results	  of	  the	  computational	  experiments	  are	  analyzed	  and	  interpreted.	  This	  generally	  involves	  the	  use	  of	  custom	  designed	  visualization	  of	  the	  resulting	  data.	  The	  investigators	  use	  the	  outputs	  of	  the	  model	  to	  determine	  what	  results	  are	  already	  useful	  for	  informing	  any	  associated	  experimental	  studies	  as	  well	  as	  what	  parts	  of	  the	  in	  silico	  model	  are	  deficient	  and	  require	  refinement	  along	  with	  a	  follow-­‐up	  round	  of	  in	  silico	  experiments.	  The	  whole	  process	  can	  be	  repeated,	  with	  refinement,	  as	  often	  as	  new	  information	  is	  required	  and	  in	  general	  the	  costs	  of	  follow-­‐up	  in	  silico	  experimentation	  decrease	  as	  the	  fundamental	  computational	  framework	  has	  already	  been	  developed.	  In	  the	  remainder	  of	  this	  section,	  we	  present	  an	  over-­‐
simplified	  and	  generic	  model	  along	  with	  the	  computational	  algorithm	  to	  further	  illuminate	  this	  concept.	  
2.1	  The	  CA	  approach	  A	  cellular	  automaton	  (CA)	  is	  a	  type	  of	  mathematical	  model,	  discrete	  in	  both	  space	  and	  time.	  Here	  we	  consider	  a	  two	  dimensional	  CA,	  such	  as	  could	  be	  used	  to	  model	  the	  surface	  of	  the	  skin	  or	  possibly	  a	  petri	  dish,	  but	  note	  that	  three	  dimensional	  models	  are	  simple,	  if	  computationally	  expensive,	  extensions	  of	  the	  same	  concepts.	  A	  two-­‐dimensional	  CA	  consists	  of	  a	  lattice	  or	  grid	  of	  CA	  elements	  covering	  a	  region	  of	  space	  (see	  Figure	  1).	  Applied	  in	  the	  biological	  context,	  each	  element	  is	  allowed	  to	  house	  one	  or	  more	  biological	  cells	  and	  depending	  on	  the	  experimental	  situation	  being	  modeled,	  may	  also	  hold	  other	  matter	  such	  as	  molecules,	  debris,	  fluid	  or	  bacteria.	  The	  cells	  in	  the	  CA	  elements	  are	  allowed	  to	  interact	  with	  one	  another	  via	  update	  rules.	  The	  set	  of	  update	  rules	  defines	  how	  the	  state	  of	  each	  element	  changes	  in	  response	  to	  its	  current	  state	  and	  the	  current	  state	  of	  its	  neighbors	  –	  the	  definition	  of	  these	  rules	  is	  the	  fundamental	  modelling	  stage	  in	  the	  development	  of	  the	  in	  silico	  model	  (see	  Figure	  2).	  The	  accuracy	  of	  the	  model	  is	  heavily	  dependent	  on	  designing	  rules	  that	  adequately	  reflect	  the	  real	  interactions	  between	  cells.	  
	  Figure	  1.	  A	  two-­‐dimensional	  grid	  is	  imposed	  on	  a	  region	  of	  space	  of	  interest	  with	  cells	  of	  different	  types,	  molecules,	  debris,	  fluid	  and/or	  bacteria	  housed	  in	  each	  element	  of	  the	  grid.	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  Figure	  2.	  The	  transition	  from	  the	  current	  state	  to	  the	  next	  state	  for	  each	  element	  of	  the	  CA	  grid	  is	  determined	  only	  by	  its	  current	  state,	  that	  of	  its	  neighbors	  and	  the	  update	  rule.	  The	  type	  of	  cellular	  automata	  model	  considered	  here	  is	  executed	  as	  follows.	  The	  system	  is	  first	  initialized	  so	  that	  the	  computational	  representation	  presented	  in	  the	  cellular	  automata	  grid	  matches	  some	  initial	  condition	  for	  the	  ensuing	  computational	  experiment.	  Next,	  a	  sequence	  of	  ‘time	  steps’	  is	  carried	  out	  such	  that	  the	  model-­‐time	  is	  incremented	  by	  a	  small	  amount	  at	  each	  step.	  Within	  each	  time	  step,	  every	  spatial	  location	  or	  element	  in	  the	  CA	  grid	  is	  investigated	  to	  identify	  its	  contents.	  Depending	  on	  the	  contents,	  an	  appropriate	  update	  rule	  is	  applied	  which	  may	  involve	  the	  states	  of	  the	  neighboring	  elements.	  Updates	  are	  made	  throughout	  the	  grid,	  time	  is	  incremented	  and	  the	  process	  continues.	  To	  extend	  this	  model	  to	  allow	  in	  silico	  trials,	  the	  computer	  program	  for	  the	  algorithm	  described	  in	  the	  above	  paragraph	  is	  wrapped	  in	  a	  further	  program.	  This	  involves	  providing	  a	  collection	  of	  two	  or	  more	  (depending	  on	  the	  number	  of	  experiments	  or	  trials	  required)	  parameter	  value	  sets	  to	  the	  algorithm	  and	  running	  the	  algorithm	  once	  with	  each	  set.	  The	  output	  data,	  for	  example	  cell	  counts	  over	  time,	  for	  each	  trial	  is	  exported	  to	  memory	  at	  the	  completion	  of	  each	  trial.	  
2.2	  Development	  of	  rules	  As	  mentioned	  earlier,	  with	  regard	  to	  developing	  an	  accurate	  description	  of	  the	  biological	  process	  of	  interest,	  the	  specification	  of	  the	  update	  rules	  for	  a	  cellular	  automata-­‐based	  in	  silico	  model	  is	  the	  most	  important	  part	  of	  the	  modelling	  process.	  To	  demonstrate	  this,	  consider	  the	  seemingly	  simple	  case	  of	  the	  movement	  of	  one	  cell	  to	  a	  neighboring	  location	  and	  the	  following	  increasingly	  complex	  but	  increasingly	  accurate	  rules.	  	  Rule	  1:	  if	  there	  is	  one	  or	  more	  empty	  CA	  elements	  surrounding	  a	  cell,	  move	  to	  a	  
randomly	  chosen	  empty	  element,	  otherwise,	  do	  not	  move.	  Rule	  2:	  if	  there	  is	  one	  or	  more	  empty	  CA	  elements	  surrounding	  a	  cell,	  and	  moving	  to	  
one	  would	  increase	  the	  cell’s	  satisfaction	  in	  some	  way,	  move	  to	  a	  randomly	  chosen	  
element	  of	  this	  type,	  otherwise,	  do	  not	  move.	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Rule	  3:	  if	  there	  is	  one	  or	  more	  empty	  CA	  elements	  surrounding	  a	  cell,	  consider	  
moving	  to	  one	  of	  these	  locations	  with	  a	  probability	  that	  depends	  on	  factors	  such	  as	  
cell	  adhesion	  levels,	  nutrient	  supply,	  chemoattractants,	  etc,	  otherwise,	  do	  not	  move.	  Each	  of	  these	  rules	  could	  be	  implemented	  in	  an	  in	  silico	  model	  as	  the	  determining	  factor	  regarding	  whether	  or	  not	  a	  cell	  moves.	  Clearly	  moving	  from	  rule	  1	  to	  rule	  3,	  the	  amount	  of	  realism	  increases,	  but	  simultaneously,	  the	  amount	  of	  information	  required	  to	  design	  the	  rule	  also	  increases.	  Rule	  1	  does	  not	  require	  any	  information	  about	  the	  cells	  of	  interest	  –	  the	  cell	  simply	  moves	  if	  it	  can	  and	  the	  location	  it	  moves	  to	  is	  randomly	  chosen.	  On	  the	  other	  hand,	  rule	  3	  requires	  that	  the	  modeler	  have	  some	  pre-­‐existing	  or	  obtainable	  understanding	  regarding	  how	  cells	  respond	  to	  chemoattractants,	  how	  cell	  adhesion	  affects	  motility	  and	  what	  impact	  nutrient	  levels	  have	  on	  the	  decision	  of	  a	  cell	  to	  move	  from	  location	  to	  location.	  Thus	  we	  note	  that	  with	  more	  information	  about	  the	  biological	  process,	  the	  modeler	  can	  construct	  more	  realistic	  update	  rules,	  but	  at	  the	  same	  time,	  a	  lack	  of	  information	  by	  no	  means	  rules	  out	  in	  silico	  modeling.	  In	  fact,	  in	  
silico	  models	  can	  yield	  rich	  information	  when	  they	  are	  used	  from	  the	  very	  early	  stages	  as	  part	  of	  hypothesis	  generation	  and	  testing	  when	  there	  is	  a	  dearth	  of	  biological	  information.	  
3.	  An	  Example	  in	  Cancer	  Biology	  Mallet	  and	  de	  Pillis	  [8]	  presented	  a	  so-­‐called	  “hybrid	  cellular	  automata	  model”	  of	  the	  interactions	  between	  the	  cells	  of	  a	  growing	  tumor	  and	  those	  of	  the	  host	  immune	  system.	  Mallet	  and	  de	  Pillis	  successfully	  designed	  a	  computational	  method	  for	  investigating	  the	  interactions	  between	  an	  idealized	  host	  immune	  system	  and	  a	  growing	  tumor.	  The	  simulated	  tumor	  growth	  experiments	  were	  found	  to	  be	  in	  qualitative	  agreement	  with	  both	  the	  experimental	  and	  theoretical	  literature.	  It	  was	  found	  that	  even	  with	  quite	  simple	  mathematical	  descriptions	  of	  the	  biological	  processes	  and	  with	  an	  overly	  simplified	  description	  of	  the	  host	  immune	  system,	  the	  computational	  model	  had	  the	  potential	  to	  produce	  the	  behavior	  observed	  in	  laboratory	  experiments	  including	  spherical	  and	  papillary	  tumor	  growth	  geometries,	  stable	  and	  oscillatory	  tumor	  growth	  dynamics,	  and	  the	  infiltration	  of	  the	  tumor	  by	  immune	  cells.	  It	  was	  also	  possible	  to	  show	  the	  dependence	  of	  these	  different	  morphologies	  on	  key	  model	  parameters	  related	  to	  the	  immune	  response.	  	  Numerical	  solutions	  produced	  using	  the	  Mallet	  and	  de	  Pillis	  model	  agreed	  qualitatively	  with	  the	  experimental	  results	  demonstrated	  by	  Zhang	  et	  al.	  [15],	  Schmollinger	  et	  al.	  [16],	  and	  Soiffer	  et	  al.	  [17].	  While	  a	  laboratory	  model	  is	  usually	  designed	  to	  focus	  on	  a	  particular	  stage	  of	  a	  process	  or	  a	  specific	  event,	  in	  silico	  models	  can	  be	  designed	  to	  focus	  on	  arbitrarily	  small	  or	  large-­‐scale	  phenomena.	  Mallet	  and	  de	  Pillis	  chose	  to	  focus	  on	  the	  early	  stages	  of	  tumor	  growth	  during	  which	  the	  tumor	  is	  adjacent	  to,	  but	  not	  yet	  infiltrated	  by,	  nutrient	  supplying	  vasculature	  in	  order	  to	  allow	  for	  an	  investigation	  of	  the	  initial	  interactions	  between	  the	  immune	  system	  and	  the	  emerging	  tumor.	  The	  simple	  model	  incorporated	  a	  simplified	  immune	  system	  comprised	  of	  two	  cell	  types,	  namely	  the	  natural	  killer	  (NK)	  cells	  of	  the	  innate	  immune	  system	  and	  the	  cytotoxic	  T	  lymphocytes	  (CTLs)	  of	  the	  specific	  immune	  system.	  A	  hybrid	  cellular	  automata	  and	  partial	  differential	  equation	  model	  was	  constructed	  with	  an	  aim	  to	  demonstrate	  the	  combined	  effects	  of	  the	  innate	  and	  specific	  immune	  systems	  on	  the	  growth	  of	  a	  two-­‐dimensional	  representation	  of	  a	  
growing	  tumor.	  This	  was	  accomplished	  by	  constructing	  a	  model	  with	  computerized	  cell	  behaviors	  built	  from	  descriptions	  in	  the	  experimental	  literature	  and	  findings	  of	  dynamic	  models	  of	  tumor–immune	  system	  interactions	  developed	  in	  the	  theoretical	  literature	  such	  as	  the	  work	  of	  Kuznetsov	  and	  Knott	  [18]	  and	  de	  Pillis	  and	  Radunskaya	  [19-­‐20].	  Mallet	  and	  de	  Pillis’	  hybrid	  cellular	  automata	  model	  employed	  a	  coupled	  deterministic–stochastic	  approach	  that	  had	  the	  benefit	  of	  being	  conceptually	  accessible	  as	  well	  as	  computationally	  straightforward	  to	  implement.	  The	  authors	  used	  reaction–diffusion	  equations	  to	  describe	  chemical	  species	  such	  as	  growth	  nutrients,	  and	  a	  cellular	  automata	  strategy	  to	  track	  the	  tumor	  cells	  and	  two	  distinct	  immune	  cell	  species.	  Together,	  these	  elements	  simulated	  the	  growth	  of	  the	  tumor	  and	  the	  interactions	  of	  the	  immune	  cells	  with	  the	  tumor–growth.	  	  The	  model	  tracked	  cells	  both	  through	  time	  and	  through	  space	  –	  a	  clear	  advantage	  over	  dynamic	  models	  that	  assume	  a	  spatially	  well-­‐mixed	  population	  of	  cells,	  which	  is	  not	  often	  the	  case	  in	  reality.	  Unlike	  continuum-­‐based	  spatiotemporal	  models,	  which	  are	  generally	  comprised	  entirely	  of	  partial	  differential	  equations,	  the	  hybrid	  cellular	  automata	  approach	  allows	  for	  the	  consideration	  of	  individual	  cell	  behavior	  and	  associated	  randomness,	  rather	  than	  applying	  a	  general	  rule	  to	  a	  collection	  of	  cells,	  as	  is	  the	  case	  with	  continuum	  models.	  The	  cellular	  automata	  approach	  is	  also	  very	  flexible	  in	  terms	  of	  its	  computational	  implementation.	  While	  the	  Mallet	  and	  de	  Pillis	  model	  considered	  only	  four	  cell	  species	  with	  an	  overly	  simplistic	  view	  of	  the	  immune	  system,	  it	  is	  easily	  modified	  to	  cater	  for	  the	  inclusion	  of	  more	  cell	  types	  or	  new	  chemical	  species.	  The	  evolution	  of	  the	  cell	  species	  considered	  in	  the	  Mallet	  and	  de	  Pillis	  model	  proceeds	  according	  to	  a	  combination	  of	  probabilistic	  and	  deterministic	  rules,	  developed	  in	  an	  attempt	  to	  describe	  the	  phenomena	  considered	  important	  in	  the	  theoretical	  model.	  	  In	  particular,	  Mallet	  and	  de	  Pillis	  imposed	  a	  simplifying	  assumption	  to	  the	  host	  cells	  such	  that,	  other	  than	  their	  consumption	  of	  nutrients,	  they	  allow	  tumor	  cells	  to	  freely	  divide	  and	  migrate	  and	  were	  more	  or	  less	  passive	  bystanders	  to	  tumor	  growth.	  Tumor	  cells	  on	  the	  other	  hand	  were	  able	  to	  move,	  divide,	  die	  due	  to	  nutrient	  levels	  and	  die	  because	  of	  the	  immune	  response,	  each	  with	  a	  probability	  that	  depended	  on	  some	  combination	  of	  nutrient	  levels,	  local	  immune	  response,	  and	  crowding	  due	  to	  the	  presence	  of	  other	  tumor	  cells.	  Natural	  killer	  cells	  were	  maintained	  at	  or	  near	  a	  ‘normal’	  level	  by	  recruitment	  from	  outside	  the	  domain	  of	  interest	  whenever	  the	  local	  density	  dropped	  too	  far	  below	  its	  equilibrium	  level.	  Both	  natural	  killer	  cells	  and	  cytotoxic	  T	  cells	  were	  able	  to	  lyse	  tumor	  cells,	  although	  CTLs	  could	  do	  so	  more	  than	  once	  and	  were	  able	  to	  attract	  other	  CTLs	  to	  the	  local	  area.	  CTLs	  were	  also	  subject	  to	  removal	  from	  the	  local	  region	  with	  a	  probability	  depending	  on	  the	  local	  tumor	  cell	  density.	  The	  rules	  used	  to	  represent	  these	  phenomena	  are	  developed	  as	  approximations	  of	  reality	  and	  involve	  considering	  individual	  events,	  such	  as	  an	  interaction	  between	  a	  cell	  on	  the	  periphery	  of	  a	  tumor	  and	  a	  natural	  killer	  cell,	  and	  attempting	  to	  quantify	  what	  happens	  as	  a	  result	  of	  this	  interaction.	  This	  act	  of	  quantifying	  is	  guided	  by	  accepted	  results	  in	  the	  experimental	  and	  theoretical	  literature,	  expert	  elicitation	  and	  simple	  physical	  arguments.	  As	  mentioned	  in	  the	  
previous	  section,	  the	  development	  of	  these	  rules	  is	  the	  most	  important	  step	  in	  model	  development.	  While	  the	  design	  and	  statement	  of	  all	  the	  CA	  rules	  are	  presented	  in	  the	  original	  paper,	  here	  we	  expand	  on	  the	  design	  of	  one	  of	  the	  rules	  to	  elucidate	  how	  such	  objects	  are	  constructed.	  Take	  for	  example	  the	  individual	  cell	  level	  event	  of	  cell	  division.	  This	  process	  is	  extremely	  complex	  and	  involves	  countless	  sub-­‐processes	  each	  with	  many	  participants.	  Just	  as	  an	  experimentalist	  in	  the	  laboratory	  does	  not	  consider	  each	  of	  these	  explicitly,	  we	  do	  not	  attempt	  to	  represent	  each	  of	  them	  in	  the	  computational	  model	  either.	  Instead,	  we	  distil	  what	  information	  is	  available	  in	  the	  literature	  and	  from	  collaborators	  to	  arrive	  at	  a	  model	  representation	  of	  the	  chance	  that	  the	  event	  occurs	  given	  certain	  conditions.	  This	  distilled	  model	  representation	  is	  the	  cellular	  automata	  rule.	  For	  the	  case	  of	  cell	  division,	  Mallet	  and	  de	  Pillis	  consider	  that	  given	  a	  tumor	  cell,	  the	  probability	  of	  division	  increases	  with	  the	  ratio	  of	  nutrient	  concentration	  to	  the	  number	  of	  tumor	  cells	  already	  present	  in	  the	  local	  region.	  Note	  that	  there	  is	  no	  mention	  of	  sub-­‐cellular	  signal	  processing	  and	  neither	  is	  there	  any	  consideration	  of	  macro-­‐level	  pressure	  fields.	  Instead,	  the	  chance	  of	  the	  occurrence	  of	  a	  cell	  division	  is	  condensed	  into	  a	  consideration	  of	  whether	  or	  not	  there	  are	  sufficient	  nutrients	  nearby	  and	  whether	  or	  not	  the	  region	  is	  already	  crowded	  with	  tumor	  cells.	  This	  rule	  is	  interesting	  because	  it	  also	  incorporates	  a	  second	  sub-­‐rule	  –	  that	  of	  the	  placement	  of	  the	  daughter	  cell.	  The	  model	  dictates	  that	  the	  grid	  location	  upon	  which	  the	  daughter	  cell	  is	  placed	  depends	  upon	  the	  cells	  occupying	  the	  neighborhood	  of	  the	  mother	  cell.	  For	  example,	  a	  dividing	  cell	  with	  at	  least	  one	  host	  cell	  or	  necrotic	  space	  surrounding	  it	  will	  place	  its	  daughter	  cell	  randomly	  in	  one	  of	  those	  non-­‐cancerous	  locations	  and	  either	  destroy	  the	  host	  cell	  or	  simply	  replace	  the	  necrotic	  material.	  On	  the	  other	  hand,	  if	  all	  elements	  around	  the	  dividing	  cell	  are	  filled	  with	  tumor	  cells,	  the	  daughter	  cell	  will	  be	  placed	  in	  the	  neighboring	  element	  containing	  the	  fewest	  tumor	  cells.	  The	  authors	  viewed	  this	  as	  one	  approach	  to	  modeling	  tumor	  cell	  crowding.	  
In	  silico	  models	  such	  as	  that	  of	  Mallet	  and	  de	  Pillis	  can	  produce	  an	  array	  of	  different	  outputs.	  In	  this	  particular	  work,	  the	  authors	  focused	  on	  presenting	  growth	  curves	  and	  two-­‐dimensional	  spatial	  snapshots	  in	  time	  of	  growing	  tumors	  that	  were	  compared	  with	  experimental	  results.	  Figures	  3	  and	  4,	  for	  example,	  show	  a	  growth	  curve	  and	  two-­‐dimensional	  snapshot	  of	  a	  tumor	  growing	  in	  the	  absence	  of	  the	  immune	  system.	  This	  result	  was	  used	  as	  a	  baseline	  to	  compare	  with	  experimental	  and	  previous	  mathematical	  results	  prior	  to	  investigating	  the	  effects	  of	  the	  immune	  system	  with	  this	  new	  model.	  Note	  in	  Figure	  3,	  the	  initially	  exponential	  growth	  phase	  (cycle	  0–200),	  before	  a	  phase	  of	  linear	  growth	  (cycle	  200–800).	  These	  growth	  characteristics	  mimic	  the	  growth	  rates	  described	  in	  the	  experimental	  work	  of	  Folkman	  and	  Hochberg	  [21]	  and	  mathematically	  by	  Greenspan	  [3].	  Figure	  4	  is	  a	  snapshot	  in	  time	  (800	  cell	  cycles)	  of	  the	  same	  simulation	  where	  we	  see	  a	  roughly	  circular	  tumor	  with	  a	  radius	  of	  about	  200	  cells	  growing	  steadily	  outward	  toward	  the	  sources	  of	  the	  nutrient.	  Higher	  tumor	  cell	  densities	  are	  seen	  at	  the	  periphery	  of	  the	  tumor	  while	  in	  the	  center,	  a	  
necrotic	  core	  is	  beginning	  to	  form	  with	  some	  necrotic	  material	  already	  appearing.	  	  
	  Figure	  3:	  An	  example	  growth	  curve	  produced	  by	  the	  Mallet	  and	  de	  Pillis	  in	  silico	  model	  showing	  total	  number	  of	  tumor	  cells	  over	  time	  for	  a	  tumor	  growing	  in	  the	  absence	  of	  immune	  response.	  	  
	  Figure	  4:	  An	  example	  two-­‐dimensional	  tumor	  growth	  after	  800	  cell	  cycles,	  simulated	  using	  the	  Mallet	  and	  de	  Pillis	  in	  silico	  model.	  Red	  intensity	  indicates	  tumor	  cell	  density.	  The	  domain	  shown	  is	  approximately	  10–20mm	  square,	  and	  growth	  is	  over	  a	  time	  period	  of	  at	  least	  a	  year.	  Mallet	  and	  de	  Pillis	  also	  presented	  a	  particularly	  interesting	  application	  of	  their	  model	  that	  produced	  qualitatively	  similar	  simulated	  tumors	  to	  the	  results	  of	  some	  recent	  experimental	  studies	  of	  immune	  response	  to	  tumor	  growth.	  The	  experimental	  studies	  of	  Schmollinger	  et	  al.	  [16],	  Soiffer	  et	  al.	  [17]	  and	  Zhang	  et	  al.	  [18]	  discussed	  the	  relationship	  between	  increased	  survival	  rates	  of	  cancer	  patients,	  tumor	  necrosis	  and	  fibrosis,	  and	  the	  presence	  of	  intratumoral	  T	  cells,	  or	  infiltrated	  T	  lymphocytes.	  In	  Figure	  5a	  and	  5b,	  immune	  cells	  are	  shown	  to	  have	  infiltrated	  a	  growing	  tumor.	  In	  particular,	  the	  darker	  regions	  in	  Figure	  5a	  are	  evidence	  of	  tumor	  necrosis	  while	  lighter	  regions	  of	  Figure	  5b	  are	  indicative	  of	  high	  immune	  cell	  populations.	  These	  solution	  plots	  are	  similar	  to	  experimental	  results	  shown	  by	  Schmollinger	  et	  al.	  [16],	  Soiffer	  et	  al.	  [17],	  and	  Zhang	  et	  al.	  [18]	  
Fig. 2(a) shows the growth in the total number of
tumor cells over time when the tumor is allowed to grow
in the absence of any immune response. Note the
initially exponential growth phase (iteration 0–200),
before a phase of linear growth (iteration 200–800).
These growth characteristics mimic the growth rates of
multicell spheroids described experimentally by Folk-
man and Hochberg (1973) and mathematically by
Greenspan (1972).
Fig. 2(b) displays the state of the system after 800
iterations. A roughly circular tumor with a radius of
about 200 cells has developed in the center of the
domain and is growing steadily toward the sources of
the nutrient. Higher tumor cell densities are seen at the
periphery of the tumor where it is surrounded by normal
cells comprising the host tissue. In the center of the
tumor a necrotic core is beginning to form with some
necrotic material already appearing. The tumor shown is
growing in a domain that is approximately 10–20mm
square, and over a time period of at least a year.
Using similar par meter values to those used by
Ferreira et al. (2002), we rep oduce the papillary tumor
results from the same paper to provide a base point for a
later consideration of the effects of the immune system.
In relation to Fig. 2, the coefficients in the nutrient
PDEs have been changed such that the rate of
consumption by tumor cells of the mitosis nutrient is
doubled, while the consumption rate of the survival
nutrient is decreased by more than half. This allows the
tumor cells to divide more rapidly in the direction of the
nutrient supply and leads to the ‘‘branchy’’ nature of the
resulting tumor shown in Fig. 3(b). Note also that a
much larger domain size was used in Fig. 2 as when the
domain sizes are smaller (as in Fig. 3), the compact
tumor grows quickly to completely cover the domain
shown and is less rounded in shape. We have used
different domain sizes in order to best show the growth
pattern of the two tumor types, prior to vascularization.
Fig. 3(a) shows the tumor cell count over time and it
can be observed that the tumor is growing exponentially
throughout the time considered without moving to a
linear growth rate (as is seen in Fig. 2(a)). It appears that
this is due to the shape of the tumor and the lower
requirements of the tumor cells for survival nutrient.
Unlike the spherical tumors for which the cell-dense
periphery limits the diffusion of nutrients to the tumor
center, the papillary tumor exhibits a fast expansion
from its origin and does not form a cell-dense periphery.
Nutrient diffusion throughout the domain is easier and
more cells are provided with the nutrients to both
survive and divide.
4.2. The effects of the immune system
In this section we investigate the changes to tumor
growth when an immune system is introduced to the
model. A review of relevant literature suggests that an
appropriate range of values for I0, the normal level of
NK cells, is quite broad. For example Kaufmann (in
Lin, 2004) suggests that the lymphocyte to tumor cell
ratio can b anywhere from 5:1 to 1:100, depending on
the tumor cell line. Cerwenker and Lanier (2001) state
that up to 15% of lymphocytes are natural killer cells,
and with lymphocytes comprising 1012 of the human
body’s 1013–1014 cells (Encyclopædia Britannica, 2004),
this gives a range for I0 of between 0:1% and 1%.
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Fig. 2. Compact tumor growth in the absence of immune system interaction. Parameter values are: domain size of 1000 elements ! 10220mm,
tend ¼ 800 cell division cycles, ynec ¼ 0:03, ydiv ¼ 0:3, ymig ¼ 1000, ln ¼ 50, lm ¼ 25, a ¼ 1, I0 ¼ 0. Note the beginning of a necrotic core in (b).
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where	  strings	  of	  immune	  cells	  are	  moving	  into	  the	  tumor,	  surrounding	  individual	  cells	  and	  causing	  tumor	  cell	  necrosis.	  The	  simulation	  results	  shown	  employee	  parameters	  for	  a	  compact	  tumor	  (in	  the	  absence	  of	  the	  immune	  system),	  low-­‐level	  CTL	  recruitment	  and	  low	  CTL	  death	  probability.	  We	  emphasize	  again	  that	  the	  same	  computer	  program	  is	  used	  to	  implement	  these	  simulations	  as	  those	  considered	  in	  the	  previous	  figures	  –	  varying	  system	  parameters	  is	  all	  that	  is	  required	  to	  consider	  quite	  a	  different	  experiment	  when	  using	  the	  in	  silico	  modeling	  technology.	  
 
(a) 
 (b)	  Figure	  5:	  Two-­‐dimensional	  snapshots	  of	  a	  tumor	  exhibiting	  high	  levels	  of	  necrosis	  (a)	  and	  populations	  of	  immune	  cells	  that	  have	  infiltrated	  the	  tumor	  mass	  causing	  cell	  death	  (b).	  The	  example	  of	  an	  in	  silico	  model	  presented	  in	  this	  section	  employed	  a	  moderately	  complex,	  hybrid	  cellular	  automata-­‐partial	  differential	  equation	  methodology	  to	  describe	  interactions	  between	  the	  host	  immune	  system	  and	  a	  growing	  tumor.	  In	  the	  absence	  of	  a	  simulated	  immune	  system,	  the	  model	  was	  capable	  of	  reproducing	  both	  compact-­‐circular	  and	  wild,	  papillary	  tumor	  morphologies.	  Morphology	  change	  was	  directly	  related	  to	  the	  relative	  rates	  of	  consumption	  of	  the	  survival	  and	  mitosis	  nutrients	  by	  both	  tumor	  and	  host	  tissue	  cells	  and	  the	  results	  presented	  correspond	  qualitatively	  with	  the	  experimental	  literature	  (such	  as	  Folkman	  and	  Hochberg	  [21]).	  When	  the	  model	  allowed	  for	  a	  simulated	  immune	  system,	  with	  different	  choices	  of	  T	  lymphocyte	  recruitment	  and/or	  death	  parameters,	  oscillatory	  growth	  curves	  were	  observed	  for	  nearly	  all	  parameter	  sets.	  Depending	  on	  the	  strength	  of	  the	  immune	  system	  recruitment	  and	  death	  parameters,	  the	  tumor	  growth	  either	  increased	  without	  bound	  or	  
resulted	  in	  destruction	  of	  the	  invasive	  growth.	  The	  model	  was	  also	  able	  to	  reproduce	  experimentally	  observed	  immune	  cell	  infiltration	  of	  growing	  tumors.	  The	  different	  sets	  of	  parameter	  values	  used	  in	  the	  simulation	  of	  the	  Mallet	  and	  de	  Pillis	  model	  are	  the	  primary	  method	  for	  computationally	  mimicking	  different	  strengths	  of	  immune	  systems	  of,	  for	  example,	  healthy	  individuals,	  capable	  of	  early	  tumor	  detection	  and	  destruction,	  and	  individuals	  in	  poor	  immune	  health,	  for	  whom	  tumors	  grow	  easily.	  In	  summary,	  even	  though	  the	  update	  rules	  proposed	  in	  the	  Mallet	  and	  de	  Pillis	  model	  were	  relatively	  simple	  and	  the	  number	  of	  cell	  types	  considered	  was	  far	  from	  exhaustive,	  the	  authors	  created	  an	  
in	  silico	  model	  that	  was	  able	  to	  produce	  results	  in	  qualitative	  agreement	  with	  both	  the	  experimental	  and	  theoretical	  literature	  and	  which	  could	  be	  improved	  upon	  to	  provide	  useful	  pre-­‐clinical	  results	  of	  relevance	  for	  further	  model	  development	  for	  guiding	  experimental	  work	  related	  to	  various	  treatment	  and	  vaccination	  strategies.	  
4.	  Conclusions	  
In	  silico	  experimental	  modeling	  of	  cancer	  involves	  combining	  findings	  from	  biological	  literature	  with	  computer-­‐based	  models	  of	  biological	  systems	  in	  order	  to	  conduct	  investigations	  of	  hypotheses	  entirely	  in	  the	  computer	  laboratory.	  In	  this	  paper	  we	  have	  presented	  a	  discussion	  of	  the	  concept	  of	  in	  silico	  modeling	  and	  how	  in	  silico	  models	  are	  constructed	  in	  practice.	  We	  have	  presented	  an	  example	  of	  in	  silico	  modeling	  that	  is	  relevant	  to	  the	  study	  of	  cancer	  and	  discussed	  its	  application	  and	  use	  as	  a	  hypothesis-­‐generating	  tool	  as	  a	  precursor	  to	  or	  in	  combination	  with	  traditional	  clinical	  and	  laboratory	  research.	  This	  type	  of	  computational	  tool,	  when	  used	  in	  transdisciplinary	  research	  teams,	  has	  the	  potential	  to	  allow	  researchers	  to	  refine	  their	  experimental	  programs	  with	  an	  aim	  to	  reducing	  costs	  and	  increasing	  research	  efficiency	  and	  we	  advocate	  increased	  use	  of	  such	  strategies	  by	  research	  groups.	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